November 12th, 2019
•We describe a quantitative real-time in vitro cytolysis assay system to evaluate the potency of chimeric antigen receptor T cells targeting liquid and solid tumor cells. This protocol can be extended to assess other immune effector cells, as well as combination treatments.
Tags
Related Videos
Retroviral Transduction of T-cell Receptors in Mouse T-cells Video (Video) | JoVE
Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells Video (Video) | JoVE
Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood Video (Video) | JoVE
Real-time Live Imaging of T-cell Signaling Complex Formation Video (Video) | JoVE
Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy Video (Video) | JoVE
Killer Artificial Antigen Presenting Cells KaAPC for Efficient In Vitro Depletion of Human Antigen-specific T Cells Video (Video) | JoVE
Simultaneous Quantification of T-Cell Receptor Excision Circles TRECs and K-Deleting Recombination Excision Circles KRECs by Real-time PCR Video (Video) | JoVE
Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells Video (Video) | JoVE
Generating De Novo Antigen-specific Human T Cell Receptors by Retroviral Transduction of Centric Hemichain Video (Video) | JoVE
Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity Video (Video) | JoVE
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved